Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are
well-established therapeutics for gastrointestinal neoplasias, but complications after …

Short designer self‐assembling peptide (dSAP) biomaterials are a new addition to the
hemostat group. It may provide a diverse and robust toolbox for surgeons to integrate wound …

Acute variceal bleeding (AVB) is a potentially fatal complication of clinically significant portal
hypertension and is one of the most common causes of acute upper gastrointestinal …

Background A recently developed haemostatic peptide gel for endoscopic application has
been introduced to improve the management of gastrointestinal bleeding. The aim of this …

Background and study aims Hemostatic powders are increasingly used to address
limitations in conventional endoscopic techniques for gastrointestinal bleeding. Various …

Background and study aims Novel topical hemostatic agents have shown promising results
in treating patients with non-variceal upper gastrointestinal bleeding (NVUGIB). However …

Background Upper gastrointestinal bleeding (UGIB) is a leading cause of morbidity and is
associated with a 2%–17% mortality rate in the UK and USA. Bleeding peptic ulcers account …

Introduction Powder hemostats are valuable adjuncts to minimize intraoperative and
postoperative complications. In addition to promotion of rapid coagulation, resorption, and …

Background & Aims Hemostatic powders have been clinically used in the treatment of
gastrointestinal bleeding. We investigated the non-inferiority of a polysaccharide hemostatic …

Abstract Background & aims Hemospray (TC-325, Cook Medical) has recently been
approved for use in GI bleeding. Specific clinical indications and predictors of success or …